An Overview of the Non-Mevalonate Pathway for Terpenoid Biosynthesis in Plants
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
ASPP2 Inhibits Tumor Growth by Repressing the Mevalonate Pathway
Liang et al. Cell Death and Disease (2019) 10:830 https://doi.org/10.1038/s41419-019-2054-7 Cell Death & Disease ARTICLE Open Access ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma Beibei Liang1,RuiChen2, Shaohua Song3,HaoWang4,GuoweiSun5, Hao Yang1,WeiJing6, Xuyu Zhou6,ZhirenFu3, Gang Huang1 and Jian Zhao1 Abstract Cancer is, fundamentally, a disorder of cell growth and proliferation, which requires adequate supplies of energy and nutrients. In this study, we report that the haplo-insufficient tumor suppressor ASPP2, a p53 activator, negatively regulates the mevalonate pathway to mediate its inhibitory effect on tumor growth in hepatocellular carcinoma (HCC). Gene expression profile analysis revealed that the expression of key enzymes in the mevalonate pathway were increased when ASPP2 was downregulated. HCC cells gained higher cholesterol levels and enhanced tumor-initiating capability in response to the depletion of ASPP2. Simvastatin, a mevalonate pathway inhibitor, efficiently abrogated ASPP2 depletion-induced anchorage-independent cell proliferation, resistance to chemotherapy drugs in vitro, and tumor growth in xenografted nude mice. Mechanistically, ASPP2 interacts with SREBP-2 in the nucleus and restricts the transcriptional activity of SREBP-2 on its target genes, which include key enzymes involved in the mevalonate pathway. Moreover, clinical data revealed better prognosis in patients with high levels of ASPP2 and low levels of the mevalonate pathway enzyme HMGCR. Our findings provide functional and mechanistic insights into the critical role of ASPP2 in the regulation of the mevalonate pathway and the importance of this pathway in tumor initiation and tumor growth, which may provide a new therapeutic opportunity for HCC. -
Understanding and Managing the Transition Using Essential Oils Vs
MENOPAUSE: UNDERSTANDING AND MANAGING THE TRANSITION USING ESSENTIAL OILS VS. TRADITIONAL ALLOPATHIC MEDICINE by Melissa A. Clanton A thesis submitted in partial fulfillment of the requirements for the Diploma of Aromatherapy 401 Australasian College of Health Sciences Instructors: Dorene Petersen, Erica Petersen, E. Joy Bowles, Marcangelo Puccio, Janet Bennion, Judika Illes, and Julie Gatti TABLE OF CONTENTS List of Tables and Figures............................................................................ iv Acknowledgments........................................................................................ v Introduction.................................................................................................. 1 Chapter 1 – Female Reproduction 1a – The Female Reproductive System............................................. 4 1b - The Female Hormones.............................................................. 9 1c – The Menstrual Cycle and Pregnancy....................................... 12 Chapter 2 – Physiology of Menopause 2a – What is Menopause? .............................................................. 16 2b - Physiological Changes of Menopause ..................................... 20 2c – Symptoms of Menopause ....................................................... 23 Chapter 3 – Allopathic Approaches To Menopausal Symptoms 3a –Diagnosis and Common Medical Treatments........................... 27 3b – Side Effects and Risks of Hormone Replacement Therapy ...... 32 3c – Retail Cost of Common Hormone Replacement -
Against the Plasmodium Falciparum Apicoplast
A Systematic In Silico Search for Target Similarity Identifies Several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast Nadlla Alves Bispo1, Richard Culleton2, Lourival Almeida Silva1, Pedro Cravo1,3* 1 Instituto de Patologia Tropical e Sau´de Pu´blica/Universidade Federal de Goia´s/Goiaˆnia, Brazil, 2 Malaria Unit/Institute of Tropical Medicine (NEKKEN)/Nagasaki University/ Nagasaki, Japan, 3 Centro de Mala´ria e Doenc¸as Tropicais.LA/IHMT/Universidade Nova de Lisboa/Lisboa, Portugal Abstract Most of the drugs in use against Plasmodium falciparum share similar modes of action and, consequently, there is a need to identify alternative potential drug targets. Here, we focus on the apicoplast, a malarial plastid-like organelle of algal source which evolved through secondary endosymbiosis. We undertake a systematic in silico target-based identification approach for detecting drugs already approved for clinical use in humans that may be able to interfere with the P. falciparum apicoplast. The P. falciparum genome database GeneDB was used to compile a list of <600 proteins containing apicoplast signal peptides. Each of these proteins was treated as a potential drug target and its predicted sequence was used to interrogate three different freely available databases (Therapeutic Target Database, DrugBank and STITCH3.1) that provide synoptic data on drugs and their primary or putative drug targets. We were able to identify several drugs that are expected to interact with forty-seven (47) peptides predicted to be involved in the biology of the P. falciparum apicoplast. Fifteen (15) of these putative targets are predicted to have affinity to drugs that are already approved for clinical use but have never been evaluated against malaria parasites. -
Of Mevalonate Metabolism'
ICANCER RESEARCH57. 3498—3505.AugustIS. 9971 Regulation of Proliferation and Ras Localization in Transformed Cells by Products of Mevalonate Metabolism' Jennifer A. Cuthbert2 and Peter E. Lipsky Department of Internal Medicine. The Unit'ersitv of Texas Southwestern Medical (‘enterat Dallas. Dallas. Texas 75235-9151 ABSTRACT position 186, the removal of the three COOH-terminal amino acids at positions 187—189, and carboxymethylation of the new COOH-termi Lovastatin, an inhibitor of 3-hydroxy.3-methylglutaryl (HMG) CoA nab cysteine. In addition, either palmitybation of other cysteine resi reductase, and 6-fluoromevalonate (Fmev), an inhibitor of diphospho dues in the COOH terminus (H-Ras, N-Ras, and K-RasA) or a mevalonate decarboxylase, blocked the synthesis of downstream meval. onate products, including prenyl-derived lipids, and prevented membrane pobybasic domain (K-RasB) is important in enhancing membrane localization of Ras in the myeloid cell line U.937. In contrast to lovastatin, association (7). These processes occur stepwise, and the first step, that which induced cytosol localization of Ras in U-937 cells, Fmev failed to of farnesybation of the full-length polypeptide, is thereby essential for increase cytosolic Ras and also completely prevented the proliferation of plasma membrane localization (12—14).Thus, compounds and muta U.937 cells. Growth of U-937 cells was restored by the addition of lovas tions that block the process of farnesylation interfere with the trans tatin to Fmev-blocked cells. These results implied that a product of formation and proliferation that are dependent upon mutationally mevalonate metabolism proximal to isopentenyl diphosphate was respon. activated Ras. -
33 34 35 Lipid Synthesis Laptop
BI/CH 422/622 Liver cytosol ANABOLISM OUTLINE: Photosynthesis Carbohydrate Biosynthesis in Animals Biosynthesis of Fatty Acids and Lipids Fatty Acids Triacylglycerides contrasts Membrane lipids location & transport Glycerophospholipids Synthesis Sphingolipids acetyl-CoA carboxylase Isoprene lipids: fatty acid synthase Ketone Bodies ACP priming 4 steps Cholesterol Control of fatty acid metabolism isoprene synth. ACC Joining Reciprocal control of b-ox Cholesterol Synth. Diversification of fatty acids Fates Eicosanoids Cholesterol esters Bile acids Prostaglandins,Thromboxanes, Steroid Hormones and Leukotrienes Metabolism & transport Control ANABOLISM II: Biosynthesis of Fatty Acids & Lipids Lipid Fat Biosynthesis Catabolism Fatty Acid Fatty Acid Synthesis Degradation Ketone body Utilization Isoprene Biosynthesis 1 Cholesterol and Steroid Biosynthesis mevalonate kinase Mevalonate to Activated Isoprenes • Two phosphates are transferred stepwise from ATP to mevalonate. • A third phosphate from ATP is added at the hydroxyl, followed by decarboxylation and elimination catalyzed by pyrophospho- mevalonate decarboxylase creates a pyrophosphorylated 5-C product: D3-isopentyl pyrophosphate (IPP) (isoprene). • Isomerization to a second isoprene dimethylallylpyrophosphate (DMAPP) gives two activated isoprene IPP compounds that act as precursors for D3-isopentyl pyrophosphate Isopentyl-D-pyrophosphate all of the other lipids in this class isomerase DMAPP Cholesterol and Steroid Biosynthesis mevalonate kinase Mevalonate to Activated Isoprenes • Two phosphates -
Biosynthesis of New Alpha-Bisabolol Derivatives Through a Synthetic Biology Approach Arthur Sarrade-Loucheur
Biosynthesis of new alpha-bisabolol derivatives through a synthetic biology approach Arthur Sarrade-Loucheur To cite this version: Arthur Sarrade-Loucheur. Biosynthesis of new alpha-bisabolol derivatives through a synthetic biology approach. Biochemistry, Molecular Biology. INSA de Toulouse, 2020. English. NNT : 2020ISAT0003. tel-02976811 HAL Id: tel-02976811 https://tel.archives-ouvertes.fr/tel-02976811 Submitted on 23 Oct 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE En vue de l’obtention du DOCTORAT DE L’UNIVERSITÉ DE TOULOUSE Délivré par l'Institut National des Sciences Appliquées de Toulouse Présentée et soutenue par Arthur SARRADE-LOUCHEUR Le 30 juin 2020 Biosynthèse de nouveaux dérivés de l'α-bisabolol par une approche de biologie synthèse Ecole doctorale : SEVAB - Sciences Ecologiques, Vétérinaires, Agronomiques et Bioingenieries Spécialité : Ingénieries microbienne et enzymatique Unité de recherche : TBI - Toulouse Biotechnology Institute, Bio & Chemical Engineering Thèse dirigée par Gilles TRUAN et Magali REMAUD-SIMEON Jury -
DIFFERENCES in Terpenoid Levels Between Plant Species Are Known To
GENETICS OF TEP.PENES I. GENE CONTROL OF MONOTERPENE LEVELS IN PINUS MONTICOLA DOUGL. JAMES W. HANOVER Geneticist, Forestry Sciences Laboratory, lntermountain Forest and Range Experiment Station, U.S. Department of Agriculture, Moscow, Idaho * Receivedi o.v.6 1.INTRODUCTION DIFFERENCESin terpenoid levels between plant species are known to exist but little is known about their genetic bases. The terpenes have been used extensively in biochemical systematic studies in Pinus (Mirov, 1958, 1961; Williams and Bannister, 1962; Forde, 1964), Eucalyptus (Baker and Smith, 1920; Penfold and Morrison, 1927), Cup ressacee (Erdtman, 1958),andmany other plant families and genera (Alston and Turner, 1963).Thesestudies were usually based upon the assumption that variation within a species is relatively small. Although this may be valid in some cases, Bannister et al. (1962)andothers have shown that the level of terpenes can vary with geographic origin within a species. Recent data on tree-to-tree variability in the monoterpenes of Pinus ponderosa Laws. show that such variation can be relatively large (Smith, 1964). Results of similar work in our laboratory with western white pine (Pinus monticola Dougi.) also revealed substantial qualitative and quantitative variation in the cortex monoterpenes between trees. In order to provide a basis for the use of terpenes for comparative biochemical studies, an understanding of both their variability and mode of inheritance is essential. The objective of the present study is to demonstrate the degree to which levels of six monoterpene compounds are gene-controlled in western white pine. Interrelations among the terpenes and between terpenes and growth are also considered, 2.MATERIALS AND METHODS Thematerials for this study are of three types: (i) parents—as clonal lines of grafts, () F1 progeny from crosses between the ortets (parents) represented by the clones, and () S1 progeny of the parent trees. -
Advances in Azorella Glabra Wedd. Extract Research: in Vitro
molecules Article Advances in Azorella glabra Wedd. Extract Research: In Vitro Antioxidant Activity, Antiproliferative Effects on Acute Myeloid Leukemia Cells and Bioactive Compound Characterization 1, , 2,3, 1 1 Daniela Lamorte * y , Immacolata Faraone y , Ilaria Laurenzana , Stefania Trino , Daniela Russo 2,3 , Dilip K. Rai 4 , Maria Francesca Armentano 2,3 , Pellegrino Musto 5 , 6 7 2,3, , 7, Alessandro Sgambato , Luciana De Luca , Luigi Milella * z and Antonella Caivano z 1 Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS CROB), 85028 Rionero in Vulture, Potenza, Italy; [email protected] (I.L.); [email protected] (S.T.) 2 Department of Science, University of Basilicata, V.le dell’Ateneo Lucano 10, 85028 Rionero in Vulture, Potenza, Italy; [email protected] (I.F.); [email protected] (D.R.); [email protected] (M.F.A.) 3 Spinoff BioActiPlant s.r.l., University of Basilicata, V.le dell’Ateneo Lucano 10, 85028 Rionero in Vulture, Potenza, Italy 4 Department of Food BioSciences, Teagasc Food Research Centre Ashtown, D15KN3K Dublin, Ireland; [email protected] 5 Hematology and Stem Cell Transplantation Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS CROB), 85028 Rionero in Vulture, Potenza, Italy; [email protected] 6 Scientific Direction, Centro di Riferimento Oncologico della Basilicata (IRCCS CROB), 85028 Rionero in Vulture, Potenza, Italy; [email protected] 7 Unit of Clinical Pathology, Centro di Riferimento Oncologico della Basilicata (IRCCS CROB), 85028 Rionero in Vulture, Potenza, Italy; [email protected] (L.D.L.); [email protected] (A.C.) * Correspondence: [email protected] (D.L.); [email protected] (L.M.); Tel.: +39-0972-726528 (D.L.); +39-0971-205525 (L.M.) These authors contributed equally to this work. -
The Composition of Cigarette Smoke I. Solanesyl Acetate
The Composition of Cigarette Smoke I. Solanesyl Acetate Alan Rodgman and Lawrence C. Cook Research Department, R. J. Reynolds Tobaeco Company Winston-Salem, North Carolina, U.S.A. Tobacco Science, 1959, 3-20, p. 86-88, ISSN.0082-4523.pdf Solanesol, an unsaturated penta confirmation of the identity of the of solanesyl acetate from the smoke terpenoid alcohol, has been identified acid was provided by conversion of of Cigarettes B was an artifact due as a constituent of flue-cured tobacco the hydrated sodium acetate to to ester interchange occurring on the at various stages of treatment by p-pheny]phenacyl acetate (Shriner adsorbent between solanesol in the Rowland, Latimer and Giles (1956). and Fuson, 1948). These data firmly particular fraction investigated and Several solanesyl esters, namely, the establish the identity of solanesyl the ethyl acetate employed as eluent. caprate, caprylate, myristate, palmi acetate as a constituent of the ciga Mold and Booth (1957) reported tate, oleate, linoleate and linolenate, rette smoke. 130 mg. of sokmesol per 1000 ciga have also been reported in an extract Two separate lots of cigarettes of rettes smoked. We found 230 mg. of of flue-cured tobacco (Rowland and the same blend were smoked during this material per 1000 Cigarettes A Latimer, 1959). Recently, Rowland this investigation. One, Cigarettes A, and 370 mg. per 1000 Cigarettes B; (1959) has identified solanesyl ace consisting of 20,000 cigarettes, gave values approximately two or three tate in an extract of flue-cured to 0.35 g. (0.0025 per cent of tobacco times that of Mold and Booth. -
Determination of Terpenoid Content in Pine by Organic Solvent Extraction and Fast-Gc Analysis
ORIGINAL RESEARCH published: 25 January 2016 doi: 10.3389/fenrg.2016.00002 Determination of Terpenoid Content in Pine by Organic Solvent Extraction and Fast-GC Analysis Anne E. Harman-Ware1* , Robert Sykes1 , Gary F. Peter2 and Mark Davis1 1 National Bioenergy Center, National Renewable Energy Laboratory, Golden, CO, USA, 2 School of Forest Resources and Conservation, University of Florida, Gainesville, FL, USA Terpenoids, naturally occurring compounds derived from isoprene units present in pine oleoresin, are a valuable source of chemicals used in solvents, fragrances, flavors, and have shown potential use as a biofuel. This paper describes a method to extract and analyze the terpenoids present in loblolly pine saplings and pine lighter wood. Various extraction solvents were tested over different times and temperatures. Samples were analyzed by pyrolysis-molecular beam mass spectrometry before and after extractions to monitor the extraction efficiency. The pyrolysis studies indicated that the optimal extraction method used a 1:1 hexane/acetone solvent system at 22°C for 1 h. Extracts from the hexane/acetone experiments were analyzed using a low thermal mass modular accelerated column heater for fast-GC/FID analysis. The most abundant terpenoids from Edited by: the pine samples were quantified, using standard curves, and included the monoter- Subba Rao Chaganti, University of Windsor, Canada penes, α- and β-pinene, camphene, and δ-carene. Sesquiterpenes analyzed included Reviewed by: caryophyllene, humulene, and α-bisabolene. Diterpenoid resin acids were quantified in Yu-Shen Cheng, derivatized extractions, including pimaric, isopimaric, levopimaric, palustric, dehydroabi- National Yunlin University of Science and Technology, Taiwan etic, abietic, and neoabietic acids. -
The NTP Generating Activity of Pyruvate Kinase II Is Critical
RESEARCH ARTICLE The NTP generating activity of pyruvate kinase II is critical for apicoplast maintenance in Plasmodium falciparum Russell P Swift, Krithika Rajaram, Cyrianne Keutcha, Hans B Liu, Bobby Kwan, Amanda Dziedzic, Anne E Jedlicka, Sean T Prigge* Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States Abstract The apicoplast of Plasmodium falciparum parasites is believed to rely on the import of three-carbon phosphate compounds for use in organelle anabolic pathways, in addition to the generation of energy and reducing power within the organelle. We generated a series of genetic deletions in an apicoplast metabolic bypass line to determine which genes involved in apicoplast carbon metabolism are required for blood-stage parasite survival and organelle maintenance. We found that pyruvate kinase II (PyrKII) is essential for organelle maintenance, but that production of pyruvate by PyrKII is not responsible for this phenomenon. Enzymatic characterization of PyrKII revealed activity against all NDPs and dNDPs tested, suggesting that it may be capable of generating a broad range of nucleotide triphosphates. Conditional mislocalization of PyrKII resulted in decreased transcript levels within the apicoplast that preceded organelle disruption, suggesting that PyrKII is required for organelle maintenance due to its role in nucleotide triphosphate generation. Introduction *For correspondence: With increasing resistance to current front-line antimalarials, there is a crucial need to find new thera- [email protected] peutic interventions with novel mechanisms of action (Dondorp et al., 2009; Trape, 2001). The api- coplast organelle within the parasite has often been considered as a source of new drug targets Competing interests: The since it is required for blood-stage survival, in addition to possessing evolutionarily distinct biochem- authors declare that no ical pathways that are not present in the human host (Goodman and McFadden, 2013; competing interests exist. -
Construction and Optimization of Mevalonate Pathway for Production Of
Construction and Optimization of Mevalonate Pathway for Production of Isoprenoids in Escherichia coli by Farnaz Nowroozi A dissertation submitted in partial satisfaction of the requirements for the degree of Joint Doctor of Philosophy with University of California, San Francisco in Engineering-Bioengineering in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Jay D. Keasling, Chair Professor Adam P. Arkin Professor Francis C. Szoka Professor Marc K. Hellerstein Fall 2009 1 The dissertation of Farnaz Foroughi-Boroujeni Nowroozi, titled Construction and Optimization of Mevalonate Pathway for production of Isoprenoids in Escherichia coli , is approved: Chair _______________________________ Date ____________________ _______________________________ Date____________________ _______________________________ Date ____________________ _______________________________ Date ____________________ University of California, Berkeley 2 Abstract Construction and Optimization of Mevalonate Pathway for production of Isoprenoids in Escherichia coli by Farnaz Foroughi-Boroujeni Nowroozi Doctor of Philosophy in Bioengineering University of California, Berkeley Professor Jay D. Keasling, Chair The isoprenoid family, containing over 50,000 members, constitutes one of the most structurally diverse groups of natural products. They range from essential and relatively universal primary metabolites, such as sterols, carotenoids, and hormones, to more unique secondary metabolites that serve roles in plant defense and communication and cellular and organismal development. Although these molecules have vast potential in medicine and industry their production is limited by two factors: 1- The yields from harvest and extraction of these compounds from their native sources are low 2- Due to their complex structure, synthetic routes to most isoprenoids are difficult and inefficient Therefore engineering metabolic pathways for production of large quantities of isoprenoids in a microbial host is an attractive approach.